Market Cap 78.92M
Revenue (ttm) 124.96M
Net Income (ttm) -21.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -17.27%
Debt to Equity Ratio 0.42
Volume 79,400
Avg Vol 242,480
Day's Range N/A - N/A
Shares Out 96.24M
Stochastic %K 26%
Beta 0.28
Analysts Strong Sell
Price Target $2.75

Company Profile

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut sy...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 224 419 7106
Fax: 510 744 8001
Address:
100 South Saunders Road, Suite 300, Lake Forest, United States
Whytheykeepmutingme
Whytheykeepmutingme Oct. 24 at 9:32 PM
0 · Reply
25_usa
25_usa Oct. 24 at 3:22 PM
$ASRT Brandon? What’s he even doing here? It’s disgraceful — he should be fired as soon as this season ends
1 · Reply
Invest2live
Invest2live Oct. 22 at 8:54 PM
$ASRT $IBIO $REKR $IBIO 80% in a few days; congrats 🎈 🌿🎉 Checkout $RXRX and $CLYM
0 · Reply
IBUYSELLHOLD
IBUYSELLHOLD Oct. 21 at 3:21 PM
$ASRT / yep, I'll invest after the split
0 · Reply
25_usa
25_usa Oct. 21 at 1:50 PM
$ASRT Rolvedon and Sympazan are the primary contributors to the company’s revenue. The company could likely sold by at least $700 million from these assets, in addition to other assets. Brandon should take an active role in the next phase to ensure that the deal is completed before the end of the year. If he is unable to do so, he should consider stepping down from the board. Two years have been sufficient to demonstrate his leadership and capabilities with this team, and his evaluation period concludes this year.
2 · Reply
Avedisian
Avedisian Oct. 20 at 9:04 PM
$ASRT This is a old claim which was paid from insurance in May qtr, this is asking for people to submit proof and get claims
2 · Reply
11thestate
11thestate Oct. 20 at 2:48 PM
$ASRT has reached a $15.95M settlement with $ASRT investors over claims that it misled them about the effectiveness and FDA approval prospects of its two lead drug candidates. The filing deadline is October 1, 2025. If you bought $ASRT between March 7, 2018, and August 5, 2021, you can file for payment here: https://11th.com/cases/spectrum-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=10202025_1
2 · Reply
EMINENZ
EMINENZ Oct. 20 at 1:18 PM
$ASRT sell the company brendan!
0 · Reply
CliffordCapital
CliffordCapital Oct. 18 at 7:34 AM
$ASRT nothing to see here. Just algos trading back and forth. Need the next ER to be great and a Brendon to give a good outlook on the company .. then we can surpass 1$ finally.
0 · Reply
Chuckuk
Chuckuk Oct. 16 at 1:43 PM
$ASRT Scrips for Rolvedon anyone?
0 · Reply
Latest News on ASRT
Assertio Holdings, Inc. (ASRT) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 7:41 PM EDT - 2 months ago

Assertio Holdings, Inc. (ASRT) Q2 2025 Earnings Call Transcript


Assertio Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:05 PM EDT - 2 months ago

Assertio Reports Second Quarter 2025 Financial Results


Assertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:17 PM EDT - 5 months ago

Assertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call Transcript


Assertio Reports First Quarter 2025 Financial Results

May 12, 2025, 4:01 PM EDT - 5 months ago

Assertio Reports First Quarter 2025 Financial Results


Assertio Holdings, Inc. (ASRT) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 6:53 PM EDT - 8 months ago

Assertio Holdings, Inc. (ASRT) Q4 2024 Earnings Call Transcript


Assertio Reports Third Quarter 2024 Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Assertio Reports Third Quarter 2024 Financial Results


Assertio Provides Response to Letter from Short-seller

Nov 11, 2024, 7:30 AM EST - 1 year ago

Assertio Provides Response to Letter from Short-seller


Assertio Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Assertio Reports Second Quarter 2024 Financial Results


Assertio: An Extremely Asymmetric Bet Skewed To The Upside

Jun 27, 2024, 9:51 AM EDT - 1 year ago

Assertio: An Extremely Asymmetric Bet Skewed To The Upside


Assertio Reports First Quarter 2024 Financial Results

May 6, 2024, 4:01 PM EDT - 1 year ago

Assertio Reports First Quarter 2024 Financial Results


Whytheykeepmutingme
Whytheykeepmutingme Oct. 24 at 9:32 PM
0 · Reply
25_usa
25_usa Oct. 24 at 3:22 PM
$ASRT Brandon? What’s he even doing here? It’s disgraceful — he should be fired as soon as this season ends
1 · Reply
Invest2live
Invest2live Oct. 22 at 8:54 PM
$ASRT $IBIO $REKR $IBIO 80% in a few days; congrats 🎈 🌿🎉 Checkout $RXRX and $CLYM
0 · Reply
IBUYSELLHOLD
IBUYSELLHOLD Oct. 21 at 3:21 PM
$ASRT / yep, I'll invest after the split
0 · Reply
25_usa
25_usa Oct. 21 at 1:50 PM
$ASRT Rolvedon and Sympazan are the primary contributors to the company’s revenue. The company could likely sold by at least $700 million from these assets, in addition to other assets. Brandon should take an active role in the next phase to ensure that the deal is completed before the end of the year. If he is unable to do so, he should consider stepping down from the board. Two years have been sufficient to demonstrate his leadership and capabilities with this team, and his evaluation period concludes this year.
2 · Reply
Avedisian
Avedisian Oct. 20 at 9:04 PM
$ASRT This is a old claim which was paid from insurance in May qtr, this is asking for people to submit proof and get claims
2 · Reply
11thestate
11thestate Oct. 20 at 2:48 PM
$ASRT has reached a $15.95M settlement with $ASRT investors over claims that it misled them about the effectiveness and FDA approval prospects of its two lead drug candidates. The filing deadline is October 1, 2025. If you bought $ASRT between March 7, 2018, and August 5, 2021, you can file for payment here: https://11th.com/cases/spectrum-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=10202025_1
2 · Reply
EMINENZ
EMINENZ Oct. 20 at 1:18 PM
$ASRT sell the company brendan!
0 · Reply
CliffordCapital
CliffordCapital Oct. 18 at 7:34 AM
$ASRT nothing to see here. Just algos trading back and forth. Need the next ER to be great and a Brendon to give a good outlook on the company .. then we can surpass 1$ finally.
0 · Reply
Chuckuk
Chuckuk Oct. 16 at 1:43 PM
$ASRT Scrips for Rolvedon anyone?
0 · Reply
Invest2live
Invest2live Oct. 15 at 7:29 PM
$REKR 106% already; congrats 🎈🎊🎉🌿 Checkout $IBIO and $ASRT; do your DD and get in.
0 · Reply
Chuckuk
Chuckuk Oct. 15 at 7:20 PM
$ASRT So just saying Udencya sold for $558 it treats like Rolvedon but doesn't have any same day prospects so what's it worth???? It is just a bit different in formulation as well.
1 · Reply
Blue_mist
Blue_mist Oct. 15 at 7:19 AM
$ASRT when are we going back to $8 again ?
0 · Reply
Invest2live
Invest2live Oct. 14 at 2:28 PM
$REKR 85% already; congrats 🎉 🎊🎈 Checkout $ASRT and $MBIO
0 · Reply
Luckybreak
Luckybreak Oct. 14 at 3:49 AM
$ASRT Rolvedon is not biosimilar like Udenyca which was recently sold by CHRS
2 · Reply
Avedisian
Avedisian Oct. 13 at 9:39 PM
$ASRT New research on same day for Neulasta, Udenyca and the other biosimilars. In summary it just can't be given, you have to go for Rolvedon if you want same day https://spcare.bmj.com/content/15/5/543
1 · Reply
caddaly
caddaly Oct. 13 at 3:13 PM
$ASRT I would really like to see this seller get finished and then a rally into earnings.
1 · Reply
Luckybreak
Luckybreak Oct. 13 at 1:39 PM
$ASRT Anyone any idea why this has market cap of $77 million and dropping when it makes so much money and has so much cash in hand compared to it’s market cap
1 · Reply
Avedisian
Avedisian Oct. 12 at 2:12 PM
$ASRT It could be that they see good sales volume coming up for Rolvedon that they negotiated a lower cost ... can't think of a reason why they would lower price.
0 · Reply
Lassekat
Lassekat Oct. 11 at 5:59 AM
0 · Reply
Ulixes1991
Ulixes1991 Oct. 10 at 10:25 PM
$ASRT good news, right? Lower COGS: https://d18rn0p25nwr6d.cloudfront.net/CIK-0001808665/b5d47d0f-db38-451b-af2f-3822f32be143.pdf
0 · Reply
Chuckuk
Chuckuk Oct. 10 at 6:19 PM
$ASRT any luck with the Scrip figures
0 · Reply